MYRIAD
INVESTOR
RELATIONS
  Myriad
     
 
    Advanced Fundamentals

Cash Flow Highlights

Security: MYGN (Common Stock)
Exchange: NASDAQ Stock Exchange (.0)
Currency: US Dollar

All values in millions unless otherwise specified.

  FY END
06/07
FY END
06/06
FY END
06/05
FY END
06/04
FY END
06/03
Assets
Net Income (Loss)-34.96-38.19-39.98-40.62-24.83
Depreciation/Amortization7.546.866.095.775.28
Net Incr (Decr) in Assets/Liab.-11.18-1.416.081.94-27.34
Cash Flow from Disc. Operationsn/an/an/an/an/a
Other Adjustments-Net12.744.724.512.030.35
Net Cash Flow from Operating-25.85-28.03-23.30-30.88-46.54
Incr (Decr) in Prop. Plant & Equip-11.40-7.68-6.74-3.88-8.04
(Acq.)Disp. of Subs. Businessn/an/an/an/an/a
Incr (Decr) in Securities Invest.-35.36-65.0526.355.91-1.08
Other Cash Flow from Investing0.02-0.10-0.10-0.10-2.85
Net Cash Flow from Investing-46.74-72.8319.521.93-11.96
Issue (Purchase) of Equity117.45149.922.4751.3359.04
Issue (Repayment) of Debtn/an/an/an/an/a
Incr (Decr) in Borrowingn/an/an/an/an/a
Dividends, Other Distributionn/an/an/an/an/a
Other Cash Inflow (Outflow)n/an/an/an/an/a
Net Cash Flow from Financing117.45149.922.4751.3359.04
Effect of Exchange Rate on Cashn/an/an/an/an/a
Cash or Equivalents at Year Start98.5749.5150.8361.6061.07
Cash or Equivalents at Year End143.4398.5749.5183.9861.60
Net Change in Cash or Equiv44.8649.06-1.3222.380.54

  
  
© 2008 Myriad Genetics, Inc.